Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Retinoblastoma].

E Bouffet1, D Frappaz, J D Grange

  • 1Service de pédiatrie, centre L-Bérard, Lyon, France.

Pediatrie
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiomics of Pediatric Low-Grade Gliomas: Toward a Pretherapeutic Differentiation of <i>BRAF-</i>Mutated and <i>BRAF</i>-Fused Tumors.

AJNR. American journal of neuroradiology·2021
Same author

Assessment of Karnofsky (KPS) and WHO (WHO-PS) performance scores in brain tumour patients: the role of clinician bias.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2020
Same author

Management of high-risk medulloblastoma.

Neuro-Chirurgie·2019
Same author

Comparison of Epidemiology and Outcomes in Neuro-Oncology Between the East and the West: Challenges and Opportunities.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019
Same author

The European Society of Paediatric Oncology Ependymoma-II program Core-Plus model: Development and initial implementation of a cognitive test protocol for an international brain tumour trial.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2019
Same author

Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same journal

[Colonic atresia: report of a case].

Pediatrie·1993
Same journal

[Psychological aspects of bone marrow donation in donor brothers and sisters in bone marrow transplantation].

Pediatrie·1993
Same journal

[Lethargy in the course of treatment with ranitidine in a newborn infant].

Pediatrie·1993
Same journal

[Delayed detection of hip dislocation: is the physician to blame?].

Pediatrie·1993
Same journal

[Renal tubular acidosis in children].

Pediatrie·1993
Same journal

[CD23: structures, functions and practical perspectives in allergy reactions].

Pediatrie·1993
See all related articles

Retinoblastoma (RB), a common childhood eye tumor, is now a model for cancer suppressor gene research. Advances enable antenatal diagnosis and aim to improve survival while reducing enucleation and radiation-induced cancers.

Area of Science:

  • Pediatric oncology
  • Ophthalmology
  • Molecular biology

Context:

  • Retinoblastoma (RB) is the most common intraocular malignancy in children.
  • Advances in molecular biology have established RB as a key model for studying cancer suppressor genes.
  • Antenatal diagnosis of retinoblastoma is now a feasible clinical option.

Purpose:

  • To review recent literature on retinoblastoma.
  • To discuss therapeutic goals including improved survival rates.
  • To highlight the reduction of iatrogenic sequelae, such as enucleation and radio-induced neoplasias.

Summary:

  • Recent literature on retinoblastoma is examined.
  • Therapeutic advancements focus on enhancing survival rates.
  • Minimizing treatment side effects like eye removal and secondary cancers is a key objective.

Related Experiment Videos

Impact:

  • Improved outcomes for pediatric cancer patients.
  • Reduced long-term morbidity associated with retinoblastoma treatment.
  • Enhanced understanding of ocular tumor biology and genetics.